Coronavirus vaccine 'Sputnik V' still under trial, efficacy yet to be ascertained: Russian analyst

India Today 2020-08-14

Views 36

In an exclusive interview to India Today, Dmitry Babich, an analyst at RIA Novosti, Moscow, Russia, said that the trials of Russian coronavirus vaccine 'Sputnik V' is not yet complete and that its efficacy has to be proven.
Show more

Share This Video


Download

  
Report form
RELATED VIDEOS
Cyclone Jawad | Exact Path Or Place Of Landfall Is Yet To Be Ascertained, Says IMD DG
play
02:21

Cyclone Jawad | Exact Path Or Place Of Landfall Is Yet To Be Ascertained, Says IMD DG
Reason Behind Wildfire In Simlipal Yet To Be Ascertained - OTV Report
play
03:45

Reason Behind Wildfire In Simlipal Yet To Be Ascertained - OTV Report
Cause Of IAF Chopper Crash Yet To Be Ascertained - OTV Report
play
03:06

Cause Of IAF Chopper Crash Yet To Be Ascertained - OTV Report
Higit 132-K doses ng Sputnik V COVID-19 vaccine, nasa bansa na; higit 30-K doses, darating ngayong gabi; Russian Amb. to the PHL, iginiit na simbolo ng matatag na relasyon ng Russia at PHL ang patuloy na vaccine delivery ng Sputnik V
play
02:36

Higit 132-K doses ng Sputnik V COVID-19 vaccine, nasa bansa na; higit 30-K doses, darating ngayong gabi; Russian Amb. to the PHL, iginiit na simbolo ng matatag na relasyon ng Russia at PHL ang patuloy na vaccine delivery ng Sputnik V
Sputnik V: Russia says Covid-19 vaccine shows 92% efficacy
play
02:13

Sputnik V: Russia says Covid-19 vaccine shows 92% efficacy
Russia's one dose 'Sputnik Light' vaccine has 80% efficacy, effective against all new covid strains
play
00:34

Russia's one dose 'Sputnik Light' vaccine has 80% efficacy, effective against all new covid strains
2nd dose supply ng Sputnik V, 'di pa rin dumarating sa bansa; Ikalawang dose, kailangang maiturok 21-42 araw matapos ang 1st dose; Mix and match ng COVID-19 vaccine brands, nakikitang solusyon para makuha ang full efficacy
play
03:11

2nd dose supply ng Sputnik V, 'di pa rin dumarating sa bansa; Ikalawang dose, kailangang maiturok 21-42 araw matapos ang 1st dose; Mix and match ng COVID-19 vaccine brands, nakikitang solusyon para makuha ang full efficacy
Coronavirus Vaccine Update: Russian Vaccine Sputnik-V के ट्रायल पर India में रोक | वनइंडिया हिंदी
play
02:41

Coronavirus Vaccine Update: Russian Vaccine Sputnik-V के ट्रायल पर India में रोक | वनइंडिया हिंदी
Pangatlong batch ng Sputnik V vaccine, inaasahang darating sa bansa sa susunod na linggo; Russia, planong magtayo ng vaccine manufacturing plant sa PHL; Russian companies, naghayag ng interes na magtayo ng mga power plant sa PHL
play
02:33

Pangatlong batch ng Sputnik V vaccine, inaasahang darating sa bansa sa susunod na linggo; Russia, planong magtayo ng vaccine manufacturing plant sa PHL; Russian companies, naghayag ng interes na magtayo ng mga power plant sa PHL
Russian vaccine Sputnik V available at three hospitals in Karachi
play
06:14

Russian vaccine Sputnik V available at three hospitals in Karachi
‘Serum Institute Seeks Permission To Manufacture Russian COVID19 Vaccine Sputnik-V’
play
01:18

‘Serum Institute Seeks Permission To Manufacture Russian COVID19 Vaccine Sputnik-V’
#LagingHanda | Russian-made COVID-19 vaccine na Sputnik-V, binigyan na ng emergency use authorization ng FDA
play
14:58

#LagingHanda | Russian-made COVID-19 vaccine na Sputnik-V, binigyan na ng emergency use authorization ng FDA